Search and Filter
Results per Page:
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Skin in the game: Changing the story of Merkel cell carcinoma
How the Nghiem Lab and its supporters are improving outcomes for patients with a rare cancer
The Beam: Updates from proton patients; new CT machine; alcohol and cancer; meet our new IT specialist
Proton patients share goals; new dual-energy CT is better for proton planning; registered dietitian weighs in on alcohol; introducing IT specialist Frank Romero
Dr. Sara Hurvitz receives the Smith Family Endowed Chair in Women’s Health
Flexible funding will fuel physician-scientist’s work to improve survivorship for women with cancer
Evolutionary cell biologist Dr. Grant King named a Hanna Gray Fellow
Long fascinated by life seen and unseen, King awarded eight years of funding to finish postdoctoral training at Fred Hutch and establish an independent lab
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Cold air makes oxygen toxic for worms
Fred Hutch study shows C. elegans, a microscopic worm, can survive low temperatures if oxygen supply is also low
Saying goodbye to a community partner and friend
Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients
Surprising findings about blood cell mutations bode well for transplant recipients
Fred Hutch researchers compared blood samples from 16 recipient-donor pairs, some more than 45 years after transplant
Tricking cells into trashing cancer
Fred Hutch chemical biologist rapidly reduces lung tumors in mice with a tagging system that grabs cancer-causing proteins and hauls them out with the molecular trash
Navigating a brand-new cancer diagnosis
Fred Hutch nurse navigation program expands, reducing waiting time for new appointments and treatment
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Leonard and Norma Klorfine Endowed Chair for Clinical Research awarded to Dr. Geoffrey Hill
Funding will help facilitate inter-institutional collaboration and foundational data capture for immunological research
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
Sharing AI insights without sharing patient data
Fred Hutch Q&A about leading alliance to leverage power of artificial intelligence responsibly in research and care
The Beam: Dr. Annemarie Shepherd on proton therapy for thymic cancers; NAPT celebrates successes and meet Dr. Winston Vuong
Why proton therapy is a good option for thymomas, national proton therapy news and the newest genitourinary specialist at the proton therapy facility